Premium
Impact of sample volume and handling time during analysis on the in vitro quality measurements of platelet concentrates held in syringes
Author(s) -
SCHUBERT P.,
CULIBRK B.,
COUPLAND D.,
LEVIN E.,
DEVINE D. V.
Publication year - 2011
Publication title -
international journal of laboratory hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.705
H-Index - 55
eISSN - 1751-553X
pISSN - 1751-5521
DOI - 10.1111/j.1751-553x.2011.01327.x
Subject(s) - in vitro , platelet , chemistry , pco2 , phosphatidylserine , plateletpheresis , chromatography , biomedical engineering , andrology , apheresis , immunology , medicine , biochemistry , membrane , phospholipid
Summary Introduction: The determination of quality parameters is a necessity for monitoring the efficacy of platelet concentrates. During consolidated quality control studies, there may be a large number of samples to be analyzed at the same time. This common workflow setup triggered the question whether there is an influence of the number of samples to be analyzed on the accuracy of the test results. Methods: Two different sample volumes of platelet concentrates, 1 ml and 50 ml, were analyzed for a set of standard in vitro parameters including pCO 2 , pO 2 , pH, glucose, and lactate as well as platelet activation via CD62P expression and responsiveness to adinosine diphosphate in an extent‐of‐shape‐change assay. To assess apoptotic mechanisms triggered by the hold time, changes in the phosphatidylserine exposure were monitored. Results: In total, eleven time points were assessed over a 3‐h period as well as an overnight point for assay evaluation. Except for pCO 2 and pO 2 , all in vitro parameters analyzed were unaffected by a sample hold time of up to 3‐h. Conclusion: Sampling for pO 2 determination should be carried out in small volumes and assessed within 30 min of collection to obtain reliable and comparable results.